Hematology UpdateApril 8-9, 2017
Presented by Seattle Cancer Care Alliance
Upon completion of this activity, attendees should be able to:
• Describe the pathogenesis, diagnostic evaluation and therapeutic modalities available for common benign and malignant hematologic diseases.
• Integrate guideline-based treatments into clinical practice while personalizing care appropriately for the patient.
• Integrate new therapeutic and diagnostic approaches into clinical practice as appropriate.
The University of Washington School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Washington School of Medicine designates this live activity for a maximum of11.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Cvent Online Event Registration Software | Copyright © 2000-2016 Cvent, Inc. All rights reserved.